Your browser doesn't support javascript.
loading
The final part of the CRESS trilogy - how to evaluate the quality of stability studies.
Cornes, Michael; Vermeersch, Pieter; Simundic, Ana-Maria; Von Meyer, Alexander; Sálek, Tomás; Meyer, Brendan; Costelloe, Sean; De Guire, Vincent; Gomez-Rioja, Ruben; Cadamuro, Janne.
Afiliación
  • Cornes M; Clinical Chemistry Department, Worcester Acute Hospitals NHS Trust, Worcester, UK.
  • Vermeersch P; Clinical Department of Laboratory Medicine, 60182 KU Leuven University Hospitals Leuven , Leuven, Belgium.
  • Simundic AM; Department of Global Medical & Clinical Affairs, Business Unit for Preanalytics, Greiner Bio-One GmbH, Kremsmünster, Austria.
  • Von Meyer A; Faculty of Pharmacy and Medical Biochemistry, Zagreb University, Zagreb, Croatia.
  • Sálek T; Institute for Laboratory Medicine and Microbiology, Munich Municipal Clinic Group, Munich, Germany.
  • Meyer B; Institute of Clinical Biochemistry and Diagnostics, Medical Faculty in Hradec Králové, Charles University, Prague, Czechia.
  • Costelloe S; Department of Clinical Biochemistry and Pharmacology, The Tomas Bata Hospital in Zlín, Zlín, Czechia.
  • De Guire V; BD Life Sciences - Winnersh, Wokingham, UK.
  • Gomez-Rioja R; Department of Clinical Biochemistry, 57983 Cork University Hospital Group , Cork, England.
  • Cadamuro J; Department of Biochemistry, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada.
Clin Chem Lab Med ; 62(11): 2128-2139, 2024 Oct 28.
Article en En | MEDLINE | ID: mdl-38747408
ABSTRACT
High quality laboratory results are critical for patient management. However, poor sample quality can impact these results and patient safety. To ensure reliable and accurate results laboratories must be aware of each analyte's stability under various storage conditions and matrices to guarantee correct and dependable outcomes. This knowledge allows laboratories to define the allowable delay between sample collection and centrifugation/analysis for all analytes to guarantee appropriate results quality and interpretation. The EFLM Working Group for the Preanalytical Phase (WG-PRE) therefore established a 4-step plan to tackle this issue, aiming to standardize and harmonize stability studies for improved comparison and meta-analysis. The plan included the development of checklists and how-to guides for performing and reporting stability studies as well as a central resource of stability data. This manuscript deals with the issue of evaluating publications and incorporating them into a central resource. To evaluate stability studies, the CRESS checklist was used to structure 20 sections used to judge the quality of studies. Each section has 4 levels of quality, with scores converted to numerical values and weighted based on expert opinion. Based on this, a final score ranging from A to D was determined. The procedure was then tested on six manuscripts and checked for agreement between expert judgements. The results demonstrated that the proposed evaluation process is a useful tool to distinguish between best in class manuscripts and those of lower quality. The EFLM WG-PRE strongly believes that the provided recommendations and checklists will help improving stability studies both in quality and standardisation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Control de Calidad Límite: Humans Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2024 Tipo del documento: Article Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Control de Calidad Límite: Humans Idioma: En Revista: Clin Chem Lab Med Asunto de la revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2024 Tipo del documento: Article Pais de publicación: Alemania